JW Jungwoo Pharmaceutical Reports Operating Loss of 7.7 Billion KRW Last Year... Returns to Deficit

[Asia Economy Reporter Oh Ju-yeon] JW Pharmaceutical announced on the 13th that its consolidated operating loss last year was 7.7 billion KRW, turning to a deficit compared to the previous year. Sales amounted to 523.8 billion KRW, down 2.5% from the previous year, and net loss for the period turned to a deficit of 20.4 billion KRW.

This content was produced with the assistance of AI translation services.